Chen et al. [35] reported that the phosphorylation of T350 in human (T345 in mouse) EZH2 (pT350-EZH2 or pT345-EZH2) is catalyzed by CDK1 or CDK2 in prostate cancer cells. This evidence concerns the gene EZH2 and prostate carcinoma.